Chronic Myeloid Leukemia

Chronic Myeloid Leukemia Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Featured

Potatinib Dosing Regimen Demonstrates Improved Responses, Survival in Patients With CP-CML

Jorge Cortes, MD, shares findings from the OPTIC trial on a dosing regimen of potatinib for patients with CP-CML. These data are being presented at the 2021 ASCO Annual Meeting.

Dr Atallah Assesses Outcomes Following the Discontinuation of TKIs in CML

Ehab L. Atallah, MD, discusses the findings of a study which looked at outcomes after TKI cessation in patients with CML.

Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML

In this podcast, Dr Hochhaus discusses the significance of the ASCEMBL trial, and proposes the question of how to eliminate persisting leukemic stem cells (LSCs) in CML.

Andreas Hochhaus, MD, on Asciminib vs Bosutinib for Pretreated CML-CP

Dr Hochhaus discusses the use of asciminib versus bosutinib for the treatment of patients with CML-CP previously given ≥2 TKIs.

Study Findings Support Use of FISH to Identify Chromosomal Abnormalities in CML

Zhenya Tang, MD, PhD, discusses the findings and clinical significance of a study he led on the use of FISH to identify chromosomal abnormalities in patients with CML.

Impact of Care Cost on TKI Adherence in Patients With CML

Gary Lyman, MD, comments on the clinical significance and findings of a study he co-conducted on the link between generic imatinib availability and trends in TKI use among patients with CML.

The Evolving Treatment Landscape for CML

Matt Kalaycio, MD, discusses how treatment for CML has evolved in the past 2 decades, and touches on the IRIS trial, which greatly impacted the treatment landscape for this disease.

TKI Therapy Interruption Recommended for Pregnant Patients With CML

Elisabetta Abruzzese, MD, PhD, discusses the history of research pertaining to patients with CML who are pregnant or planning to start a family.

Data Support Using Bosutinib Therapy for Treatment of Chronic-Phase CML

Sonia Amin Thomas, PharmD, BCOP, discusses data regarding the safety and efficacy of bosutinib therapy for patients with chronic-phase CML.